Mr. Del Dietrich, Commercial Real Estate Broker*

As the President of American Commercial Realty, Inc. Mr. Dietrich has been handling real-estate brokerage and marketing for 22 years.  He will be advising Diversified on real estate development, property valuation and government entitlements for permitting and construction.  Mr. Dietrich specializes in disposition, commercial leasing, and project due diligence.  He has provided Disposition Analyses and Broker Price Opinions for the United States Bankruptcy Court, banks, pension fund advisors and private investors.  Municipal planning commissions and redevelopment agencies have sought his help with general plan amendments, code compliance and mitigation and conditional use permits.  Mr. Dietrich has represented corporate and individual clients in over $1 Billion of Silicon Valley real estate transactions.  Much of this representation involved office, industrial, and land development projects.

Mr. Ken Holman, Senior Project Manager - Construction Management*

Mr. Holman has over eighteen years of experience in project management, turn-key design build procurement, and business development for one of the leading General Contractors in the Silicon Valley.  His extensive experience includes clean rooms, bio-pharmaceutical labs, medical facilities, building retrofits, and new building construction.  Most recently, Ken has concentrated on the benefit analysis of the collaborative design-build approach to technical projects and the inherent cost and time savings gained by utilizing this approach.  Ken will be providing his expertise in the areas of cost analysis for various types of construction methods and techniques and site selection. He earned a Bachelors Degree in Construction Management from Cal Poly San Luis Obispo in 1988.

Mr. Don Iverson, Professional Engineer*

Mr. Iverson has over twenty-five years of experience in project management, engineering, and construction administration for building mechanical systems.  His extensive experience includes engineering and design of special piping and plumbing systems as well as complex ventilation, steam, and liquid heat-transfer systems for heating and air conditioning.  While Don has direct engineering experience in virtually all types of buildings, most of his career has been oriented toward the more complex systems typically found in laboratory and health care facilities, including Swedish Cancer Institute – Seattle, Loma Linda University Medical Center, Evergreen Hospital, St. Francis Hospital, Providence Hospital Medical Center, Stevens Memorial Hospital, Washington State University Veterinary Science Building and Point Defiance Zoo Animal Hospital.  Don has a hands-on, yet very team-oriented approach to developing sensible and cost effective systems for the most demanding applications.  His continuous involvement in a project, from concept development through successful Owner occupancy, is routine.  Mr. Iverson will be advising Diversified on its corporate objectives as they relate to the design and construction of facilities. 

Dr. Keith Knopes, M.D.*

Dr. Knopes is an Anesthesiologist at the Virginia Mason Medical Center in Seattle, and a Clinical Assistant Professor at the University of Washington.  His specialties include cardiac anesthesiology, cardiovascular pharmacology, and intra-operative pharmacology.  With over 30 years experience in operations management, sales, marketing, and business development in the medical sector, Dr. Knopes will provide DBMI with valuable medical and business perspective.  He earned his M.D. at the Stanford University School of Medicine in 1981, interned at Duke Medical Center in 1982, and completed his residency at Duke University in 1986.

Dr. Mark Lee, Operations and Facilities Development*

Dr. Lee began his career in a family-owned real estate and insurance business in Ontario in 1984. In 1991, after completing his MBA, Mark moved to Saskatchewan to teach undergraduate business at Briercrest College, in Saskatchewan, then later taught graduate studies in leadership and management.  While at Briercrest, Mark also took on the role of Vice President of Finance and Operations, which required doing a significant turnaround of the organization’s finances and operations.  In 1999, Mark became the President & CEO of Lakeland College in Alberta.  During his tenure as President, the College grew from 3,000 students to over 10,000 students, and grew revenues from $24 million to around $47 million.  In the summer of 2005, Dr. Lee left Lakeland to return to the classroom at Trinity Western University.  Since arriving at Trinity Western University, Mark has been appointed the Director of the MBA program, and has launched both the MBA program and the iMBA program.

As a senior executive and professor with advanced training in both finance and human resource management, Dr. Lee has experience in academic, non-profit, and entrepreneurial environments.  He has been effective at re-envisioning organizations, defining strategies and communicating the vision to all levels of organization.  Dr. Lee has led various organizations through significant changes in organizational structure and culture by implementing an empowerment leadership paradigm, which resulted in significant growth and revenues.

Dr. Lee received a B.Sc. in Psychology from York University, Toronto, Ontario in 1984.  He received his MBA in Finance and Management from Liberty University, Lynchburg, Virginia in 1991 and a D.B.A. in Human Resource Management from Nova Southeastern University, Ft. Lauderdale, Florida in 1995. 

Mr. Garry Montgomery, Chairman & CEO

Mr. Garry Montgomery has spent the last 30 years in start-up entrepreneurial positions and has significant experience in the areas of business development, legal, accounting and regulatory compliance. A twenty year veteran of the life sciences sector, he has worked extensively in Medical Informatics, Therapeutics, and Pharmaceutics.

Mr. Montgomery has experience in senior management positions with both public and private sector companies, laying foundations and setting strategic direction for the corporate development of those companies. His experience with start-up and early-stage ventures includes: defining corporate long-range objectives, operations, building company infrastructure and management teams, concluding private equity placements, setting and executing exit strategies for building shareholder value. He has proven experience as a visionary, establishing and directing companies for successful attainment of both short and long-term corporate objectives and revenue milestones.

Mr. Montgomery studied at Briercrest College (BRE), University of Minnesota, Simon Fraser University (BA), and the University of British Columbia. His academic focus was business and business education.

Mr. Patrick M. Murphy, Operation and Development*

Patrick Murphy is Vice President of Operations at Solstice Neurosciences, Inc. with global headquarters located in Malvern, Pennsylvania, and Manufacturing and Customer Support located in South San Francisco, California. Solstice is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of toxins. Solstice’s first approved product, Myobloc® Injectable Solution (also know as NeuroBloc® in Europe) represents the only botulinum toxin type B currently available to physicians and patients worldwide. At Solstice, Patrick is responsible for Manufacturing, quality assurance, quality control, facilities, materials management, production planning, technical operations and engineering.

Prior to joining Solstice Neurosciences, Patrick worked at Acologix, Inc, as Vice President of CMC and Operations. Acologix is a biology-based biopharmaceutical company focusing on the identification and development of novel therapeutics for major unmet medical needs. Acologix strives to improve patients’ lives by developing and commercializing innovative biopharmaceuticals targeting “osteo-renal” (bone and kidney) diseases. His responsibilities included contract manufacturing, quality assurance, quality control, pharmaceutical development and operations.

Prior to joining Acologix, Patrick worked at Abgenix, Inc. for 5 years, most recently as Senior Vice President of Production Services. His responsibilities included manufacturing, contract manufacturing, process sciences, quality assurance, quality control, materials management, purchasing and other support functions. As Vice President of Manufacturing, he was responsible for manufacturing, contract manufacturing, engineering, facilities, environmental health and safety, security, materials management, logistics, purchasing and office management. Abgenix is a biopharmaceutical company focused on the development and commercialization of human therapeutic antibodies.

Prior to joining Abgenix, Patrick worked at Genentech, Inc. for nearly 19 years. During that time, he held various positions including Director of Strategic Operations and Director of Biochemical Manufacturing. Patrick played a key role in the development and commercialization of numerous molecules as well as in the design, construction, start up and subsequent approval of many facility projects. He has extensive experience in process scale up, technology transfer and modeling.

Prior to joining Genentech, Patrick worked at Dynapol, Inc. for 5 years. During that time, he held various positions in manufacturing and process development. Dynapol developed and manufactured polymeric food dyes and polymeric antioxidants for use in foods.

Patrick received a BS degree in Biochemistry from the State University of New York at Binghamton in 1976.

Mr. Terry C. Niehaus, VP, CFO

Mr. Niehaus is a senior executive with more than 25 years experience in accounting and finance, in the development and implementation of effective business strategies in manufacturing, systems and software companies with responsibility emphasis in operations management, finance, cost control, systems development and planning.  He is responsible for the financial affairs of Diversified Bio-Medics, Inc., and provides financial and commercial input into the strategic direction of the company.

Mr. Niehaus serves as Controller, Electronics Group, Crane Co. (NYSE – CR).  The Electronics Group of Crane Co. is a manufacturer.  Terry has 7 direct and 28 indirect financial professionals from 7 business units reporting to him.  Mr. Niehaus has served clients in manufacturing, software and healthcare where he was instrumental in raising invested capital.  Mr. Niehaus has also participated in a successful turnaround of a manufacturing company, making it the most profitable business unit owned by Mitsui & CO., USA.

Mr. Niehaus is a CPA and holds a BBA from the University of Cincinnati.

Mr. Edward Onyon, VP, Secretary

During the past 30 years Mr. Edward Onyon has held numerous management and executive positions in public, private, and ethnic minority organizations. He has extensive experience in human resource management, vocational training, manufacturing, quality control, sales engineering, retail, and in oversight of various special projects including business expansion construction. He has also served as a consultant to business.

Mr. Onyon’s education and broad business sector experience has made him a valued member of management teams in the U.S.A. and Mexico. He has also served on various Boards for charity, a county library system,and a municipal Civil Service Commission.

Mr. Onyon has studied at the University of California at Irvine and Santa Clara, the University of Chicago, and was an MBA candidate at Pepperdine University. He earned his Bachelor of Arts degree at California State Long Beach.

Mr. Reed W. Simmons, MBA, Operations/Corporate Development*

Mr. Reed W. Simmons, a senior biotechnology and biomedical executive, has over 30-years of biomedical and biotechnology management experience.  For more than 18-years, Mr. Simmons held various manufacturing and operational management positions, directly related to biotechnology and biomedical manufacturing, for divisions of pharmaceutical companies Smith-Kline Beckman, Bristol-Myers Squibb, and Sanofi-Synthelabo S.A.  In 1985, Mr. Simmons joined the management team of one of Seattle’s earliest biotechnology start-ups, Genetic Systems Corporation, and was an integral part of developing and commercializing the company’s first products.  Those efforts resulted in one of the first Establishment and Biological Product Licenses for HIV in the U.S., and eventually, four additional Biological Product Licenses.  From 1993 to 1999, Mr. Simmons was Vice-President & General Manager of a U.S. operating division of the French pharmaceutical company Sanofi-Synthelabo S.A., then the owner of Genetic Systems Corporation, and held full U.S. P&L responsibility in that role.  In 1999, the division was sold to Bio-Rad Laboratories of Hercules, CA.  Mr. Simmons has since turned his interests to working with start-up and emerging biotechnology and biomedical companies by providing consultation and interim operational management and support.

Mr. Simmons is recognized for developing strong, high-performance teams, successfully managing highly complex projects, and proactively leading organizations through change and has a broad experience managing heavily regulated global and start-up businesses.

Mr. Simmons holds a MBA from Pepperdine University, School of Business Management, with an emphasis in Operations Management and Quantitative Analysis.  Mr. Simmons also studied at Loma Linda University, School of Medicine, with an emphasis in Pharmacology.

Mr. Hank Szeto, Senior Director of Engineering and Facilities - Facilities Development*

Mr. Hank Szeto brings over 27 years of experience from major pharmaceutical/biotechnology operating companies.  He is recognized as a veteran in the industry for his solid project and organization leadership, and for his ability to build and manage strong, cohesive, high performance teams.   Starting with the design and construction of the first large scale mammalian cell culture plant in the United States, through the conclusion of the Vacaville Second Manufacturing Site, Mr. Szeto has provided direction and technical expertise for most of Genentech’s pilot and manufacturing facilities, R&D labs, and vivariums.  More recently, Mr. Szeto completed an award-winning cGMP Clinical Manufacturing Plant for Abgenix.  This project is distinguished by its functionality, cost effectiveness, and short, aggressive construction schedule.  Mr. Szeto holds a Bachelor of Science degree in Mechanical Engineering and Minor in Industrial Engineering from the California Polytechnic State University in San Luis Obispo.

* Denotes Advisory Board Position